Friday, June 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 165 of 1,261

  1. US 2023321198

    Dosage Regimen for a Controlled-Release PTH Compound

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Oct 12, 2023 · Expires Oct 7, 2043

    granted

  2. US 11779625

    Composition and application thereof in preparing product for protecting mitochondria

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  3. US 11779657

    Compositions and methods for mitochondrial genome editing

    The Regents of the University of California · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  4. US 11780845

    FGFR inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  5. US 11780805

    Carbamoyl phenylalaninol compounds and uses thereof

    AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  6. US 11780839

    Compounds for treating Huntington's disease

    PTC THERAPEUTICS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  7. US 11781143

    Modulators of PNPLA3 expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  8. US 11781101

    3D-printed models of biological microenvironments

    Regents of the University of Minnesota · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  9. US 11780879

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    The Board of Regents of the University of Texas System · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  10. US 11780852

    Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile

    Theravance Biopharma R&D IP, LLC · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  11. US 11781110

    Induction of corneal endothelial cells

    The Regents of the University of California · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  12. US 11780885

    Zika viral antigen constructs

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  13. US 11779660

    Viral vectors for cancer therapy

    Krystal Biotech, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  14. US 11782065

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  15. US 11781247

    Variable epitope library compositions and methods of therapeutic and prophylactic use

    Primex Clinical Laboratories, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  16. US 11781955

    Photo-controlled removal of targets in vitro and in vivo

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  17. US 11781156

    Plakophillin-2 gene therapy methods and compositions

    Tenaya Therapeutics, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  18. US 11779635

    Subcutaneous administration of ADAMTS13

    Takeda Pharmaceutical Company Limited · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  19. US 11779554

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  20. US 11779601

    Diagnostic methods for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  21. US 11778995

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  22. US 11779603

    HERV-E reactive T cell receptors and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  23. US 11779578

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  24. US 11779565

    Small organic molecules for use in the treatment of neuroinflammatory disorders

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.